A METHOD FOR PREDICTING CLINICAL OUTCOME OF PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA

• 1. 一种用于非小细胞肺癌患者免疫治疗的预后评估方法 [P] . 中国专利： CN113851185A . 2021-12-28
• 2. 一种非小细胞肺癌患者疗效及预后预测系统 [P] . 中国专利： CN112116977A . 2020-12-22
• 3. Method for predicting clinical outcome of patients with non-small cell lung carcinoma [P] . 美国专利： US8728738B2 . 2014-05-20

  机译： 非小细胞肺癌患者临床预后预测方法

• 4. Method for Predicting Clinical Outcome of Patients With Non-Small Cell Lung Carcinoma [P] . 美国专利： US2011269637A1 . 2011-11-03

  机译： 非小细胞肺癌患者临床预后的预测方法

• 5. A METHOD FOR PREDICTING CLINICAL OUTCOME OF PATIENTS WITH NON-SMALL CELL LUNG CARCINOMA [P] . 世界知识产权组织专利： WO2010000796A1 . 2010-01-07

  机译： 一种非小细胞肺癌患者临床预后的预测方法

• 1. Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data [J] . Ashley M. Hopkins, Adel Shahnam, Sasha Zhang, 癌症生物学与医学（英文版 ） . 2019,第002期
• 2. Prognostic model of survival outcomes in non-small cell lung cancer patients initiated on afatinib: pooled analysis of clinical trial data [J] . Ashley M. Hopkins, Adel Shahnam, Sasha Zhang, 癌症生物学与医学：英文版 . 2019,第002期
• 3. Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method: a single-center large-scale investigation of 1,504 Chinese Han patients [J] . Lin Yang, Yun Ling, Lei Guo, 中国癌症研究（英文版） . 2016,第005期
• 4. Early Tumor and Nodal Response in Patients with Locally Advanced Non-Small Cell Lung Carcinoma Predict for Oncologic Outcomes in Patients Treated with Concurrent Proton Therapy and Chemotherapy [J] . Grewal Amardeep S., Min Eun Jeong, Long Qi, International Journal of Radiation Oncology, Biology, Physics . 2020,第2期
• 5. Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab [J] . Simonaggio A., Elaidi R., Fournier L., Cancer immunology, immunotherapy : . 2020,第12期
• 6. TCR Repertoire Diversity of Peripheral PD-1(+)CD8(+) T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non-Small Cell Lung Cancer [J] . Han Jiefei, Duan Jianchun, Bai Hua, Cancer immunology research. . 2020,第1期
• 7. A proteomic signature of relapse-related death predicting clinical outcome in human non-small cell lung cancer [C] . Kiyoshi Yanagisawa M.D., Shuta Tomida, Yukako Shimada, ASMS Conference on Mass Spectrometry and Allied Topics . 2006
• 8. Clinical outcomes of patients with non-small cell lung carcinoma: a retrospective study. [D] . Decker, Brandee. 2013
• 9. Low Infiltration of CD8+ PD-L1+ T Cells and M2 Macrophages Predicts Improved Clinical Outcomes After Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Carcinoma [O] . Liuning Li, Guojie Lu, Yang Liu, 2021
• 10. EP1.16-13 Characteristics and Clinical Outcomes in Patients with Non-Small Cell Lung Carcinoma in Fundacion Santa Fe De Bogota: 42 Months Experience [O] . A.V. Ospina Serrano, L.E. Pino Villareal, J.M. Segovia Gomez, 2019

• 1. Use of programmed cell death protein ligand 1 assay to predict the outcomes of non-small cell lung cancer patients treated with immune checkpoint inhibitors [J] . Carmelo Tibaldi ,Alice Lunghi ,Editta Baldini . 世界临床肿瘤学杂志：英文版 . 2017,第4期
• 2. TT genotype of GNAS1 T393C polymorphism predicts better outcome of advanced non-small cell lung cancer patients [J] . Hong-Yun Gong ,Wei-Guo Hu ,Xiu-Ling Wang . 世界胃肠肿瘤学杂志：英文版（电子版） . 2014,第12期
• 3. 青年非小细胞肺癌患者临床特点与预后因素分析 [C] . 游庆军 . 第13届全国肺癌学术大会 . 2013
• 4. 预后营养指数评估中晚期非小细胞肺癌患者预后的临床应用价值 [A] . 许文娟 . 2016